Benefits of Rituximab Combined With Intravenous Immunoglobulin for Desensitization in Kidney Transplant Recipients

Cryptic B Cell Response to Renal Transplantation

(2013) R. J. Lynch et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab

(2013) Ashley A. Vo et al.   TRANSPLANTATION

Rituximab Prevents an Anamnestic Response in Patients With Cryptic Sensitization to HLA

(2013) Andrea A. Zachary et al.   TRANSPLANTATION

Analysis of Anti-HLA Antibodies in Sensitized Kidney Transplant Candidates Subjected to Desensitization with Intravenous Immunoglobulin and Rituximab

(2013) Andrew L. Lobashevsky et al.   TRANSPLANTATION

B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells

(2012) Tom A. Barr et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Lack of Effect in Desensitization With Intravenous Immunoglobulin and Rituximab in Highly Sensitized Patients

(2012) Kwaku Marfo et al.   TRANSPLANTATION

Chronic Antibody-Mediated Rejection Is Reduced by Targeting B-Cell Immunity During an Introductory Period

(2011) N. Kohei et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Desensitization Protocols and Their Outcome

(2011) K. Marfo et al.   Clinical Journal of the American Society of Nephrology

Infectious Complications in Kidney-Transplant Recipients Desensitized with Rituximab and Intravenous Immunoglobulin

(2011) J. Kahwaji et al.   Clinical Journal of the American Society of Nephrology

Desensitization in HLA-Incompatible Kidney Recipients and Survival

(2011) Robert A. Montgomery et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibody Testing Strategies for Deceased Donor Kidney Transplantation After Immunomodulatory Therapy

(2011) Chih-Hung Lai et al.   TRANSPLANTATION

Calculated PRA: Initial Results Show Benefits for Sensitized Patients and a Reduction in Positive Crossmatches

(2010) J. M. Cecka et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation

(2010) C. Lefaucheur et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Advances in diagnosing and managing antibody-mediated rejection

(2010) Stanley C. Jordan et al.   PEDIATRIC NEPHROLOGY

Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study

(2010) Alexandre Loupy et al.   TRANSPLANTATION

Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

(2010) Ashley A. Vo et al.   TRANSPLANTATION

The Use of Immunoglobulin Therapy for Patients Undergoing Solid Organ Transplantation: An Evidence-Based Practice Guideline

(2009) Nadine Shehata et al.   TRANSFUSION MEDICINE REVIEWS

The Spectrum of Antibody-Mediated Renal Allograft Injury: Implications for Treatment

(2008) J. Gloor et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

(2008) Ashley A. Vo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Acceptable Donor-Specific Antibody Levels Allowing for Successful Deceased and Living Donor Kidney Transplantation After Desensitization Therapy

(2008) Nancy L. Reinsmoen et al.   TRANSPLANTATION